95125-1
LaboratorySARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay
Definition
Qualitative detection of IgA and IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. The assay does not distinguish between IgA and IgM.
LOINC 6-Axis Classification
Component
SARS coronavirus 2 Ab.IgA+IgM
Property
PrThr
Time Aspect
Pt
System
Ser/Plas
Scale Type
Ord
Method Type
IA
Details
Class
MICRO
Order/Observation
Both
Short Name
SARS-CoV-2 IgA+IgM SerPl Ql IA
Display Name
SARS-CoV-2 (COVID-19) IgA+IgM IA Ql
Related Names
Frequently Asked Questions
What is LOINC code 95125-1?
LOINC code 95125-1 identifies "SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay". Qualitative detection of IgA and IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. The assay does not distinguish between IgA and IgM.
What does 95125-1 measure?
This code measures SARS coronavirus 2 Ab.IgA+IgM in Ser/Plas. It belongs to the MICRO class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.